Newsmax IPO: A Historic Surge Followed by a Dramatic Decline Explosive Market Debut The recent Initial Public Offering (IPO) of Newsmax, a right-wing cable television network, captured headlines with its extraordinary performance on the New York Stock Exchange. Priced initially at **$10 per share**, Newsmax saw its stock—traded under the ticker symbol NMAX—skyrocket to close …
Continue reading “Newsmax IPO: A Stunning Rise and Fall in Stock Performance Explained”
Gold Prices Surge as Trump’s Reciprocal Tariffs Reshape Import Landscape Gold prices have soared to unprecedented heights following President Donald Trump’s announcement of sweeping tariff revisions, marking a significant shift in America’s trade relationships and its impact on consumer costs. The precious metal climbed to a record $3,201.60 per ounce in aftermarket trading based on …
Larry Fink’s Annual Letter: A Shift Toward Pragmatism and Away from Political Discourse Each year, the financial world anticipates the release of Larry Fink’s letter, written by the CEO of BlackRock, the world’s largest asset manager, with $11.5 trillion in assets under management. This letter serves as a critical touchpoint for investors and analysts on …
How Trump’s Tariffs Could Backfire: A Cautionary Tale from Reagan As the world watches the onset of President Trump’s second term, the economic policies reminiscent of his first administration come back into focus. Particularly, his stance on tariffs evokes Ronald Reagan’s warning that while tariffs “sometimes for a short while [work]—but only for a short …
Continue reading “How Trump’s Tariffs Might Derail Economic Stability: Lessons from Reagan’s Era”
Axsome’s Sunosi Trial Yields Mixed Results, Showing Promise for MDD with Daytime Sleepiness In a recent announcement, Axsome Therapeutics revealed that its investigational drug, Sunosi (solriamfetol), has demonstrated mixed results in a phase 3 trial aimed at treating patients with major depressive disorder (MDD), particularly those experiencing excessive daytime sleepiness (EDS). A week after celebrating …
MicroStrategy Faces First Bearish Analyst: Why Investors Should Consider Selling In a significant shift in sentiment on Wall Street, MicroStrategy Inc. (ticker: MSTR), now doing business as Strategy, has received its first bearish recommendation from analyst Gus Gala of Monness Crespi Hardt. This downgrade comes on the heels of the company’s recent aggressive moves to …
Investors Turn to Gold Amid Rising Credit Risks: Insights from Keith Weiner Gold Prices Surpassing $3,100 an Ounce With the global economy showing signs of strain, it’s no wonder that gold is currently trading at over $3,100 an ounce. According to Keith Weiner, CEO and founder of Monetary Metals, the ascent in gold prices is …
Trump to Review Preliminary TikTok Deal As Deadline Approaches As the deadline for TikTok’s operational status in the United States looms, President Trump is scheduled to review a significant proposal that aims to either facilitate the app’s continued operation or lead to its sale. This meeting, set to take place on Wednesday, will involve notable …
Continue reading “Trump Reviews Crucial TikTok Deal Amid Deadline Pressure: What’s at Stake?”
Goldman’s Stagflationary Outlook: Revised S&P 500 Target and Rising Recession Risks As the April 2 tariff deadline approaches, financial markets are bracing for further uncertainty. In a recent note, analysts from Goldman Sachs have painted a grim picture for the S&P 500, cutting their short-term target amid growing concerns over stagflation. Market Context: Strain on …
What We Know and Don’t Know About Trump’s April 2 Tariffs President Donald Trump has characterized April 2 as “Liberation Day,” announcing the rollout of new tariffs on imported goods that has caused a stir in financial markets and among trade experts. The specifics surrounding these tariffs seem fluid, with Trump reportedly advocating for a …
Continue reading “Understanding Trump’s April 2 Tariffs: Key Insights and Market Reactions”
